Clinical Trials Directory

Trials / Completed

CompletedNCT03332745

Mechanism of Decompensation Evaluation - Aortic Stenosis

Mechanism of Left Ventricular Decompensation Evaluation - Aortic Stenosis

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
University of Edinburgh · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Aortic stenosis is the most common heart valve disease requiring intervention in high income countries. It is characterised by progressive valvular thickening, and restriction as well is hypertrophy and fibrosis of the left ventricle in response to pressure overload. The pathological processes in the left ventricle that ultimately result in heart failure and death are incompletely understood. Further elucidation of these processes and how they correlate with novel blood biomarkers may help us design new treatments and optimise the timing of surgical intervention. In brief, recruited patients with severe aortic stenosis and scheduled to undergo valve replacement surgery will be invited for some simple tests (blood sampling, ECG, echocardiogram). A septal myocardial biopsy will be taken at the time of surgery and the disease valve retained. These will be examined histologically and pathological changes compared with results obtained from ECG, echocardiogram and blood tests.

Conditions

Timeline

Start date
2018-09-03
Primary completion
2021-08-12
Completion
2023-07-31
First posted
2017-11-06
Last updated
2024-05-13

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03332745. Inclusion in this directory is not an endorsement.